- IN₹90.12bn
- IN₹94.47bn
- IN₹34.20bn
Brief: India's Sequent Scientific Sept-Qtr Profit Falls
Brief: India's Sequent Scientific June Qtr Consol Profit Rises
Brief: India's Sequent Scientific June Qtr Consol Profit Rises
Brief: Sequent Scientific Says Unit Received Approval For Manufacturing Unit In Turkey
Brief: Sequent Scientific Says Solara Active Pharma Sciences Got Final Listing Approval From BSE, NSE
Brief: India's Sequent Scientific March-Qtr Consol Profit Rises
Brief: Strides Shasun Says NCLT Approves Co's Scheme Of Arrangement With Sequent Scientific And Solara Active Pharma Sciences
Brief: Sequent Scientific Says NCLT Approved Composite Scheme Between Co, Strides Shasun, Solara Active Pharma Sciences
Brief: India's Sequent Scientific Dec Qtr Consol Loss Narrows
Brief: Sequent Scientific Gets Shareholders' Nod For Scheme Of Arrangement with Strides Shasun
Brief: Strides Shasun Gets Shareholders' Nod For Composite Scheme Of Arrangement With Sequent Scientific And Solara Active Pharma Sciences
Brief: India's Sequent Scientific posts Sept-qtr profit
Brief: Sequent Scientific seeks shareholders' nod for appointment of Sharat Narasapur as joint MD
Brief: India's Sequent Scientific posts June-qtr consol profit
Brief: SeQuent Scientific's Alivira registers 3 products in Ukraine
Brief: Sequent Scientific says Alivira gets US FDA approval for Visakhapatnam facility
Brief: Sequent Scientific says co gets members' nod for divestment of Naari Pharma
Brief: Strides Shasun approves scheme of arrangement with Sequent Scientific, SSL Pharma Sciences
Brief: Sequent Scientific Dec qtr consol loss narrows